We next wondered whether later, at 48 h after Dex treatment, there might be changes in cell morphology and anti-apoptotic Bcl-2 protein content, up-regulated in T-cell acute lymphoblastic leukemia [31]. This evidence concerns the gene BCL2 and T-cell acute lymphoblastic leukemia.